← All trials

NCT04652102

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 14, 2020
Primary completion
Mar 5, 2021
Completion date
Mar 4, 2023
First posted
Dec 3, 2020
Last posted
Dec 21, 2020
Enrollment
36500
Arms / groups
4 / —
Source
AACT · ingestion pipeline

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.